Galectin Therapeutics Reports First Quarter 2012 Financial Results
Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of
therapeutics that target galectin proteins to treat fibrosis and cancer,
today reported its financial results for first quarter, ended March 31,
Motorcar Parts of America, Inc. (NASDAQ:MPAA), Galectin Therapeutics Inc. (NASDAQ:GALT) and Town Sports International Holdings, Inc. (NASDAQ:CLUB) started off this Wednesday strong and are among the...